GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sophia Genetics SA (NAS:SOPH) » Definitions » Scaled Net Operating Assets

Sophia Genetics (Sophia Genetics) Scaled Net Operating Assets : 0.22 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Sophia Genetics Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Sophia Genetics's operating assets for the quarter that ended in Mar. 2024 was $76.52 Mil. Sophia Genetics's operating liabilities for the quarter that ended in Mar. 2024 was $30.58 Mil. Sophia Genetics's Total Assets for the quarter that ended in Dec. 2023 was $206.16 Mil. Therefore, Sophia Genetics's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.22.


Sophia Genetics Scaled Net Operating Assets Historical Data

The historical data trend for Sophia Genetics's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sophia Genetics Scaled Net Operating Assets Chart

Sophia Genetics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial 0.16 0.20 0.18 0.12 0.19

Sophia Genetics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.19 0.20 0.23 0.22

Competitive Comparison of Sophia Genetics's Scaled Net Operating Assets

For the Health Information Services subindustry, Sophia Genetics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sophia Genetics's Scaled Net Operating Assets Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sophia Genetics's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Sophia Genetics's Scaled Net Operating Assets falls into.



Sophia Genetics Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Sophia Genetics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(82.905-36.113)/243.838
=0.19

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=206.156 - 123.251
=82.905

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=54.714 - 15.673 - 2.928
=36.113

Sophia Genetics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2024 )
=(Operating Assets (Q: Mar. 2024 )-Operating Liabilities (Q: Mar. 2024 ))/Total Assets (Q: Dec. 2023 )
=(76.523-30.584)/206.156
=0.22

where

Operating Assets(Q: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=180.258 - 103.735
=76.523

Operating Liabilities(Q: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=48.026 - 14.738 - 2.704
=30.584

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sophia Genetics Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Sophia Genetics's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Sophia Genetics (Sophia Genetics) Business Description

Traded in Other Exchanges
Address
Rue du Centre 172, Saint-Sulpice, CHE, CH-1025
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities.